كتاب إلكتروني

Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)

التفاصيل البيبلوغرافية
العنوان: Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)
المؤلفون: Carde, P.Aff5, Gonçalves, E.Aff5, Isnard, F.Aff5, de Paillette, E. DeschampsAff5, Chastang, C.Aff5, Mathieu-Tubiana, N.Aff5, Vuillemin, E.Aff5, Delwail, V.Aff5, Corbion, O.Aff5, Vekhoff, A.Aff5, Ferrero, J.-M.Aff5, Garcia-Giralt, E.Aff5, Gimonet, J.-F.Aff5, Stoppa, A. M.Aff5, Leger-Picherit, E.Aff5, Monpezat, J.-P.Aff5, Fadel, E.Aff5, Domenge, C.Aff5, Guilhot, F.Aff5, Thomas, F.Aff5, Khayat, D.Aff5, Monnier, A.Aff5, Zittoun, R.Aff5, Brun, B.Aff5, Maraninchi, D.Aff5, Munck, J.-N.Aff5, Beaujan, F.Aff5, Guigon, M.Aff5, Frindel, E.Aff5, Najman, A.Aff5, Tubiana, M.Aff5
المساهمون: Banzet, P., editorAff1, Holland, J. F., editorAff2, Khayat, D., editorAff3, Weil, M., editorAff4
المصدر: Cancer Treatment An Update. :843-849
قاعدة البيانات: Springer Nature eBooks
الوصف
ردمك:9782817807676
9782817807652
DOI:10.1007/978-2-8178-0765-2_179